Clinical Trials Browser

Phase 2 × Non Squamous Non Small Cell Lung Cancer × Clear all

NCT05841472 2023-08-30

Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Phase 2 Recruiting

Non Squamous Non Small Cell Lung Cancer

NCT05962021 2023-08-01

Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR Mutation

Phase 2 Not yet recruiting

Non Squamous Non Small Cell Lung Cancer